| Q37522587 | "Contrast nephropathy" in renal transplantation: Is it real? |
| Q48738912 | A case of CTO treated with minimum use of contrast media |
| Q46167256 | A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. |
| Q38181853 | A critical appraisal of intravenous fluids: from the physiological basis to clinical evidence |
| Q33305487 | A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity |
| Q38230626 | Accuracy of point-of-care serum creatinine devices for detecting patients at risk of contrast-induced nephropathy: a critical overview |
| Q53068292 | Acute kidney damage induced by low- and iso-osmolar contrast media in rats: Comparison study with physiologic MRI and histologic-gene examination. |
| Q39850340 | Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function |
| Q34455487 | Albuminuria and Estimated Glomerular Filtration Rate Independently Associate with Acute Kidney Injury |
| Q83641837 | Are we still wondering or wandering in the dark? |
| Q40683122 | Breviscapine attenuatted contrast medium-induced nephropathy via PKC/Akt/MAPK signalling in diabetic mice |
| Q58998989 | Computed Tomography Angiography before Intravenous Thrombolysis Does Not Increase the Risk of Renal Dysfunction |
| Q46984931 | Conservative outpatient renoprotective protocol in patients with low GFR undergoing contrast angiography: a case series |
| Q36713541 | Contemporary imaging modalities for the surveillance of patients with renal cell carcinoma |
| Q37922124 | Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines |
| Q38202647 | Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies |
| Q55690513 | Contrast-Enhanced Cross Sectional Imaging and Capsule Endoscopy: New Perspectives for a Whole Picture of the Small Bowel. |
| Q42269781 | Contrast-induced acute kidney injury: the importance of diagnostic criteria for establishing prevalence and prognosis in the intensive care unit |
| Q37977872 | Contrast-induced kidney injury: mechanisms, risk factors, and prevention |
| Q36761998 | Contrast-induced nephropathy following angiography and cardiac interventions |
| Q64072396 | Contrast-induced nephropathy in an animal model: Evaluation of novel biomarkers in blood and tissue samples |
| Q33929305 | Contrast-induced nephropathy in patients undergoing intravenous contrast-enhanced computed tomography in Korea: a multi-institutional study in 101487 patients |
| Q40123147 | Contrast-induced nephropathy in patients with aneurysmal subarachnoid hemorrhage |
| Q43180123 | Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: risk-factors and prognostic value |
| Q36576632 | Contrast-induced nephropathy--a review of current literature and guidelines. |
| Q88687007 | Correlating abdominal pain and intra-abdominal injury in patients with blunt abdominal trauma |
| Q48783900 | Decreased infarct volume and intracranial hemorrhage associated with intra-arterial nonionic iso-osmolar contrast material in an MCA occlusion/reperfusion model |
| Q34816125 | Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort study |
| Q34229453 | Does this adult patient have a blunt intra-abdominal injury? |
| Q36425063 | Effect of N-acetyl cysteine in prevention of contrast nephropathy on patients under intravenous pyelography and contrast CT |
| Q64985938 | Effect of astaxanthin on apoptosis of rat renal tubular epithelial cells induced by iohexol. |
| Q36143434 | Effectiveness of N-Acetylcysteine for the Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials |
| Q55318504 | Glomerular filtration decrease after diagnostic cardiac catheterisation in children with congenital cardiac malformation - the role of serum creatinine, cystatin C, neutrophil gelatinase and urine output monitoring. |
| Q40165811 | High-pitch carbon dioxide contrasted CT angiography: pilot study |
| Q79760100 | How to protect from contrast media-induced nephropathy? |
| Q85329433 | Hypernatremia is a significant risk factor for acute kidney injury after subarachnoid hemorrhage: a retrospective analysis |
| Q22306070 | Hypertensive Crises |
| Q42986096 | Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease |
| Q33861539 | Impact of the interval between coronary angiography and off-pump coronary bypass surgery on postoperative renal function. |
| Q37563780 | Intravenous therapy for hypertensive emergencies, part 1. |
| Q34453548 | Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media |
| Q56968775 | Komplikationen durch die Kontrastmittelgabe |
| Q91166011 | Laboratory Predictors of Contrast-Induced Nephropathy After Neurointervention: A Prospective 3-Year Observational Study |
| Q64898460 | MicroRNA expression profile by next-generation sequencing in a novel rat model of contrast-induced acute kidney injury. |
| Q37977061 | N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review |
| Q35803600 | N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis. |
| Q81305644 | NGAL is an early predictive biomarker of contrast-induced nephropathy in children |
| Q37817813 | Nephrotoxicity of contrast media and protective effects of acetylcysteine |
| Q38199743 | Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography |
| Q33945154 | Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury |
| Q51838501 | New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. |
| Q37001266 | Non-contrast 3D time-of-flight magnetic resonance angiography for visualization of intracranial aneurysms in patients with absolute contraindications to CT or MRI contrast |
| Q40675192 | Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial |
| Q48252777 | Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury |
| Q38690013 | Physicochemical properties of radiographic contrast media, potential nephrotoxicity and prophylaxis |
| Q35626471 | Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography |
| Q50090707 | Post-contrast acute kidney injury - Part 1: Definition, clinical features, incidence, role of contrast medium and risk factors : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines. |
| Q35999430 | Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography |
| Q88141737 | Prevention of Contrast and Radiation Injury During Coronary Angiography and Percutaneous Coronary Intervention |
| Q57024984 | Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: study protocol for a randomised controlled trial |
| Q27012899 | Prophylaxis of contrast-induced nephrotoxicity |
| Q51471405 | Protective effect of beta-glucan on contrast induced-nephropathy and a comparison of beta-glucan with nebivolol and N-acetylcysteine in rats. |
| Q53543544 | Protective effect of salidroside on contrast-induced nephropathy in comparison with N-acetylcysteine and its underlying mechanism. |
| Q37251655 | Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy |
| Q36107057 | Renal Protective Effect of Probucol in Rats with Contrast-Induced Nephropathy and its Underlying Mechanism |
| Q91656098 | Renal dysfunction in cirrhosis |
| Q26753127 | Renal protection in cardiovascular surgery |
| Q80243394 | Risk of contrast-induced nephropathy in patients with normal renal function: iso-osmolar versus low-osmolar medium |
| Q26796473 | Risk prediction models for contrast induced nephropathy: systematic review |
| Q43614019 | Risk score for the prediction of contrast-induced nephropathy in elderly patients undergoing percutaneous coronary intervention |
| Q43121489 | Screening for renal insufficiency following ESUR (European Society of Urogenital Radiology) guidelines with on-site creatinine measurements in an outpatient setting |
| Q42418082 | Simvastatin attenuates contrast-induced nephropathy through modulation of oxidative stress, proinflammatory myeloperoxidase, and nitric oxide |
| Q37585848 | Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis |
| Q36666993 | Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic |
| Q38380615 | Statins in the prevention of contrast-induced nephropathy |
| Q30879334 | Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study |
| Q91687204 | The correlation of post-operative acute kidney injury and perioperative anaemia in patients undergoing cardiac surgery with cardiopulmonary bypass |
| Q46140548 | The diagnosis and treatment of hypertensive crises |
| Q35574190 | The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury |
| Q42336264 | The prevention of acute kidney injury: an in-depth narrative review Part 1: volume resuscitation and avoidance of drug- and nephrotoxin-induced AKI |
| Q37680397 | The protective effect of single dose tadalafil in contrast-induced nephropathy: an experimental study. |
| Q34661076 | The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials |
| Q53638881 | The usefulness of carvedilol and nebivolol in preventing contrast nephropathy in rats. |
| Q40707858 | Three-dimensional angiography-guided percutaneous transluminal angioplasty for distal aorta and bi-iliac chronic total occlusion |
| Q22306013 | Toxicity of MRI and CT contrast agents |
| Q37079104 | Treatment of acute severe hypertension: current and newer agents. |
| Q39110308 | Understanding and preventing contrast-induced acute kidney injury |
| Q100440286 | Use of Intravenous Iodinated Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation |
| Q44973660 | Use of alpha-lipoic acid in prevention of contrast-induced nephropathy in diabetic patients |
| Q52923652 | [Iodinated contrast agent-induced nephropathy]. |
| Q22242895 | ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el |